We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.

ESCEND Projectlogo

Phase II early esophageal cancer detection study started

Results of real-time VEGFA-targeted NIR-FME

source: GUT BMJ

 

Our Phase II early esophageal cancer (EC) detection study ESCEND started, coordinated by Vasilis Ntziachristos. The study follows exciting results showing up to 40% improvement in early EC using fluorescence molecular aging.

 

Partners

Helmholtz Zentrum München
Logo of Helmholtz Zentrum München
University Medical Center Groningen
Logo of University Medical Center Groningen
XVue Ltd.
Logo of XVue Ltd.

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.